CD274 and cancer: Notably, there was an increase in the expression of genes encoding PDL-1 receptors, which are targeted in cancer immune therapies, suggesting a potential enhancement in the therapeutic effectiveness of monoclonal antibodies targeting PDL-1 (Figure 6A).